Bladder cancer markers in patient management: the current perspective

B. J. Schmitz-Dr?ger; Y. Fradet; H. B. Grossman

首页> 外文期刊>World Journal of Urology >Bladder cancer markers in patient management: the current perspective

【24h】

Bladder cancer markers in patient management: the current perspective

机译：膀胱癌患者管理中的标志物：当前观点

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《World Journal of Urology》 |2008年第1期|1-3|共3页
作者
B. J. Schmitz-Dr?ger; Y. Fradet; H. B. Grossman;
展开▼
作者单位

Urologie EuromedClinic Europa-Allee 1 90763 Fürth Germany;

L’Hotel-Dieu de Québec Centre Hospitalier Universitaire de Québec Québec QC Canada;

M. D. Anderson Cancer Center University of Texas Houston TX USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Bladder cancer markers in patient management: the current perspective. [J] . Schmitz-Drager BJ, Fradet Y, Grossman HB World journal of urology . 2008,第1期

机译：病人管理中的膀胱癌标志物：当前观点。
2. Reply from Authors re: Marko Babjuk. Second resection for non-muscle-invasive bladder carcinoma: Current role and future perspectives. Eur Urol 2010;58:191-2 and Giacomo Novara, Vincenzo Ficarra. Does routine second transurethral resection affect the long-term outcome of patients with t1 bladder cancer? why a flawed randomized controlled trial cannot address the issue. Eur Urol 2010;58:193-4 [J] . DivrikR.T., ?ahinA.F., Erg?rG. European urology . 2010,第2期

机译：作者的回复：Marko Babjuk。非肌肉浸润性膀胱癌的第二次切除：当前作用和未来展望。 Eur Urol 2010; 58：191-2和Giacomo Novara，文森佐·费卡拉（Vincenzo Ficarra）。常规第二次经尿道切除术是否会影响t1膀胱癌患者的长期结局？为什么有缺陷的随机对照试验不能解决这个问题。欧元（Uur Urol）2010; 58：193-4
3. Current perspectives in bladder cancer management [J] . GriffithsT.R.L. International journal of clinical practice . 2013,第5期

机译：膀胱癌管理的最新观点
4. MRI Markers for Early Assessment of Bladder Cancer: A Review [C] . Kamal Hammouda, Fahmi Khalifa, Mohammed Ghazal, IEEE International Symposium on Signal Processing and Information Technology . 2018

机译：膀胱癌早期评估的MRI标记：综述
5. Understanding treatment-related symptoms, symptom management techniques, and symptom management self-efficacy in a sample of non-muscle invasive bladder cancer patients [D] . Hinojosa-Lindsey, Marilyn 2010

机译：了解非肌肉浸润性膀胱癌患者样本中与治疗相关的症状，症状管理技术和症状管理自我效能
6. Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes [O] . Maurice M. Garcia, Alexander R. Gottschalk, Jonathan Brajtbord, -1

机译：校正：内镜金基准标记放置在膀胱壁中以优化放射治疗针对肌肉浸润性膀胱癌的膀胱保存管理的目标：可行性和初步结果
7. Correction: Endoscopic Gold Fiducial Marker Placement into the Bladder Wall to Optimize Radiotherapy Targeting for Bladder-Preserving Management of Muscle-Invasive Bladder Cancer: Feasibility and Initial Outcomes [O] . Maurice M. Garcia, Alexander R. Gottschalk, Jonathan Brajtbord, 2016

机译：校正：内窥镜金基准标记放置到膀胱壁中，优化靶向膀胱膀胱膀胱癌的膀胱保存管理的放射疗法：可行性和初始结果
8. Tumor Marker CA 125: The Clinical Significance of the Serum Marker CA 125 in the Management of Patients with Ovarian Cancer [R] . van der Burg, M. E. L. 1989

机译：肿瘤标志物Ca 125：血清标志物Ca 125在卵巢癌患者管理中的临床意义

Bladder cancer markers in patient management: the current perspective

著录项

相似文献

相关主题

期刊订阅